🟢 Clearpoint Neuro is trading 5% up today amid broader market gains

Clearpoint Neuro is trading at $11.45, up 5.09%, with broader risk-on sentiment the likeliest context; no company-specific catalyst was identified.

• U.S. stocks are higher, with the S&P 500 up 0.65% and the Nasdaq Composite up 1.14%.
• The earlier uniQure Huntington’s therapy setback and ClearPoint Neuro’s recent sell-off are prior context, not new October 5 announcements.